LabCorp
LH
#1029
Rank
NZ$37.83 B
Marketcap
NZ$455.35
Share price
-0.32%
Change (1 day)
15.40%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2025 (TTM): NZ$17.62

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$17.72. In 2024 the company made an earnings per share (EPS) of NZ$15.37 an increase over its 2023 EPS that were of NZ$8.13.

EPS history for LabCorp from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.6214.65%
2024NZ$15.3789.15%
2023NZ$8.13-66.26%
2022NZ$24.09-43.33%
2021NZ$42.5054.11%
2020NZ$27.5889.43%
2019NZ$14.56-3.33%
2018NZ$15.06-29.7%
2017NZ$21.4275.74%
2016NZ$12.1963.19%
2015NZ$7.47-28.4%
2014NZ$10.43-6.13%
2013NZ$11.115.2%
2012NZ$10.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Quest Diagnostics
DGX
NZ$14.94-15.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.52-108.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-102.05%๐Ÿ‡บ๐Ÿ‡ธ USA
IDEXX Laboratories
IDXX
NZ$21.98 24.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.23-81.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands